Latest News about BBH
Recent news which mentions BBH
Drug Price Debate May Not Hinder Biotech ETFs After All
September 16, 2021
From ETF Trends
Biotech Stocks Have Colds, but They Can Heal
September 13, 2021
From ETF Trends
Moderna Vaccine Is Granted Authorization in Australia
August 09, 2021
From ETF Trends
SEC’s Gary Gensler may have just laid out the clearest road map to the first U.S. bitcoin ETF
August 05, 2021
From MarketWatch
Tickers
BBH
From ETF Trends
From ETF Trends
Tickers
BBH
From ETF Trends
Post-Pandemic Healthcare Could Feature More Biotech M&A
June 10, 2021
From ETF Trends
As AMC’s stock surged, an Invesco ‘reopening’ fund sold shares of the meme because that is how the smart-beta ETF works
June 10, 2021
From MarketWatch
From ETF Trends
Fintech Focus For June 9, 2021
June 08, 2021
From Benzinga
5 Top ETFs With Exposure To Biogen
June 07, 2021
From Benzinga
Biogen Could Send Biotech ETFs on a Wild Ride
June 07, 2021
From ETF Trends
From ETF Trends
From Benzinga
From ETF Trends
From ETF Trends
Biotech Shined with Vaccines. It Can Do It Again with ‘BBH’
March 03, 2021
Tickers
BBH
From ETF Trends
10 ETFs to Buy to Mimic 2021’s Best Stock Picks
February 24, 2021
From InvestorPlace
Illumina Earnings, Forward Guidance Strengthen Biotech ETFs
February 12, 2021
From ETF Trends
Biotechnology ETFs Soar on Biogen’s New Alzheimer’s Drug
January 29, 2021
From ETF Trends
ALPS ‘SBIO’ ETF: Trial Progress Meets Investing Success
January 25, 2021
From ETF Trends
Don’t Miss Out on Rampant Biotech Mergers with the SBIO ETF
January 13, 2021
From ETF Trends
3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover
December 14, 2020
From Benzinga
As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally
December 03, 2020
From ETF Trends
How Will Vaccine Arrivals Affect Biotech ETFs?
November 30, 2020
From ETF Trends
How Increased FDA Activity Can Benefit ETFs in Your Portfolio
November 19, 2020
From ETF Trends
Bullish on Biotech? The BBH ETF is Not Just a 2020 Play
November 18, 2020
Tickers
BBH
From ETF Trends
Biotech ETFs Poised for Gains after Moderna Vaccine News
November 16, 2020
From ETF Trends
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.